Immunoassay screening of diphenhydramine (Benadryl(R)) in urine and blood using a newly developed assay.

Article Details

Citation
Copy to clipboard

Rodrigues WC, Castro C, Catbagan P, Moore C, Wang G

Immunoassay screening of diphenhydramine (Benadryl(R)) in urine and blood using a newly developed assay.

J Anal Toxicol. 2012 Mar;36(2):123-9. doi: 10.1093/jat/bkr015.

PubMed ID
22337782 [ View in PubMed
]
Abstract

Diphenhydramine (DPH) is a common over the counter antihistamine that produces drowsiness and has the potential to cause driving under the influence of drugs-related accidents. To date there are no commercially available immunoassay screening kits for its detection in biological fluids such as urine and/or blood. We describe a newly developed enzyme-linked immunosorbent assay (ELISA) screen and report on its utility in the analysis of authentic specimens taken from volunteers. The assay is specific for detection of DPH and does not detect closely related antihistamines like brompheniramine, chlorpheniramine, and doxylamine. There is a varying amount of cross-reactivity seen with certain tricyclic compounds, due to similarities in side chain structure with DPH. Intra- and interday precision of the assay were determined to be less than 10%. The assay is highly sensitive and has a working range from 1 to 500 ng/mL for urine and 1 to 250 ng/mL for blood. The assay was further validated with authentic urine and blood specimens obtained from volunteers and coroner's laboratories.

DrugBank Data that Cites this Article

Drugs